Purpose: This study aimed to evaluate the diagnostic efficacy of time-dependent diffusion magnetic resonance imaging (td-dMRI) and dynamic contrast-enhanced MRI (DCE-MRI)-based kinetic heterogeneity in differentiating suspicious breast lesions (categorised as Breast Imaging Reporting and Data System 4 or 5).
Methods: This prospective study included 51 females with suspicious breast lesions who underwent preoperative breast MRI, including DCE-MRI and td-dMRI. Six kinetic parameters, namely peak, persistent, plateau, washout component, predominant curve type, and heterogeneity, were extracted from the DCE series using MATLAB and SPM software. The td-dMRI data were analysed using the JOINT model to obtain five microstructural parameters and apparent diffusion coefficient at 50 ms (ADC). Chi-square or Fisher's exact test and the Mann-Whitney U test were used to compare these parameters between benign and malignant breast lesions. Univariate and multivariate logistic regression analyses with forward stepwise covariate selection were performed to identify significant clinical and radiologic variables. Differential diagnostic performance was evaluated using receiver operating characteristic curves and logistic regression analyses.
Results: For td-dMRI-derived parameters, the values of f and cellularity were significantly higher in malignant breast lesions compared to benign lesions (P = 0.001 and P<0.001, respectively), while ADC was significantly lower in malignant lesions (P = 0.001). In the kinetic heterogeneity analysis, the washout component was higher in malignant lesions compared to benign lesions (P = 0.003). When combining significant td-dMRI and kinetic heterogeneity parameters, the area under the curve (AUC) value was 0.875, with an accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of 82.69 %, 86.11 %, 75.00 %, 88.57 %, and 70.59 %, respectively. Notably, margin and kinetic pattern emerged as independent predictors of malignant breast lesions (P = 0.019 and 0.006, respectively). Furthermore, incorporating these two clinical-radiologic characteristics further enhanced diagnostic accuracy, yielding an AUC of 0.969, with accuracy, sensitivity, specificity, PPV, and NPV improving to 90.38 %, 86.11 %, 100 %, 100 %, and 76.19 %, respectively.
Conclusions: Kinetic heterogeneity- and td-dMRI-derived parameters are potentially non-invasive biomarkers for distinguishing suspicious breast lesions.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.mri.2025.110323 | DOI Listing |
Cureus
December 2024
General Surgery, Rajendra Institute of Medical Sciences, Ranchi, IND.
Phyllodes tumor is a type of fibroepithelial neoplasm involving the breast. This tumor is rarely reported in adolescents and the elderly and has a peak incidence in middle-aged women. Histologically, phyllodes tumors are classified as benign, borderline, or malignant.
View Article and Find Full Text PDFFront Oncol
December 2024
Department of Pathology, Weifang Hospital of Traditional Chinese Medicine, Weifang, Shandong, China.
Ductal carcinoma (DCIS), a noninvasive breast cancer, rarely metastasises to distant locations. When the initial lesion is stable, bone marrow metastasis (BMM) and bone marrow necrosis (BMN) are even less common. Here, we report the case of a 47-year-old female patient who underwent localized surgery and radiotherapy for right-sided DCIS.
View Article and Find Full Text PDFMed Phys
January 2025
Department of Scientific Research and Academic, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, Liaoning, P. R. China.
Background: This study aims to explore the value of habitat-based magnetic resonance imaging (MRI) radiomics for predicting the origin of brain metastasis (BM).
Purpose: To investigate whether habitat-based radiomics can identify the metastatic tumor type of BM and whether an imaging-based model that integrates the volume of peritumoral edema (VPE) can enhance predictive performance.
Methods: A primary cohort was developed with 384 patients from two centers, which comprises 734 BM lesions.
Nat Med
January 2025
Department of Medicine-Medical Oncology, University of Colorado Cancer Center, Denver, CO, USA.
Effective targeting of somatic cancer mutations to enhance the efficacy of cancer immunotherapy requires an individualized approach. Autogene cevumeran is a uridine messenger RNA lipoplex-based individualized neoantigen-specific immunotherapy designed from tumor-specific somatic mutation data obtained from tumor tissue of each individual patient to stimulate T cell responses against up to 20 neoantigens. This ongoing phase 1 study evaluated autogene cevumeran as monotherapy (n = 30) and in combination with atezolizumab (n = 183) in pretreated patients with advanced solid tumors.
View Article and Find Full Text PDFSci Rep
January 2025
Department of Obstetrics and Gynecology, Mianyang Central Hospital, University of Electronic Science and Technology of China, Mianyang, 621000, Sichuan, China.
Objective Endometrial lesions are a frequent complication following breast cancer, and current diagnostic tools have limitations. This study aims to develop a machine learning-based nomogram model for predicting the early detection of endometrial lesions in patients. The model is designed to assess risk and facilitate individualized treatment strategies for premenopausal breast cancer patients.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!